106 related articles for article (PubMed ID: 16099905)
1. Increase in infectivity of targeted Moloney murine leukemia virus-based gene-delivery vectors through lowering the threshold for fusion.
Viejo-Borbolla A; Thomas P; Blair ED; Schulz TF
J Gen Virol; 2005 Sep; 86(Pt 9):2469-2480. PubMed ID: 16099905
[TBL] [Abstract][Full Text] [Related]
2. Insertion of targeting domains into the envelope glycoprotein of Moloney murine leukemia virus (MoMLV)-based vectors modulates the route of mCAT-1-mediated viral entry.
Viejo-Borbolla A; Pizzato M; Blair ED; Schulz TF
Virus Res; 2005 Mar; 108(1-2):45-55. PubMed ID: 15681054
[TBL] [Abstract][Full Text] [Related]
3. Targeted infection of a retrovirus bearing a CD4-Env chimera into human cells expressing human immunodeficiency virus type 1.
Matano T; Odawara T; Iwamoto A; Yoshikura H
J Gen Virol; 1995 Dec; 76 ( Pt 12)():3165-9. PubMed ID: 8847525
[TBL] [Abstract][Full Text] [Related]
4. Membrane-proximal cytoplasmic domain of Moloney murine leukemia virus envelope tail facilitates fusion.
Rozenberg-Adler Y; Conner J; Aguilar-Carreno H; Chakraborti S; Dimitrov DS; Anderson WF
Exp Mol Pathol; 2008 Feb; 84(1):18-30. PubMed ID: 18222422
[TBL] [Abstract][Full Text] [Related]
5. An essential role for the His-8 residue of the SDF-1alpha-chimeric, tropism-redirected Env protein of the Moloney murine leukemia virus in regulating postbinding fusion events.
Katane M; Fujita R; Takao E; Kubo Y; Aoki Y; Amanuma H
J Gene Med; 2004 Mar; 6(3):260-7. PubMed ID: 15026987
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of the R peptide cleavage site of Moloney murine leukaemia virus envelope protein.
Kubo Y; Amanuma H
J Gen Virol; 2003 Aug; 84(Pt 8):2253-2257. PubMed ID: 12867658
[TBL] [Abstract][Full Text] [Related]
7. Membrane fusion and cell entry of XMRV are pH-independent and modulated by the envelope glycoprotein's cytoplasmic tail.
Côté M; Zheng YM; Liu SL
PLoS One; 2012; 7(3):e33734. PubMed ID: 22479434
[TBL] [Abstract][Full Text] [Related]
8. Targeting retroviral vectors to vascular lesions by genetic engineering of the MoMLV gp70 envelope protein.
Hall FL; Gordon EM; Wu L; Zhu NL; Skotzko MJ; Starnes VA; Anderson WF
Hum Gene Ther; 1997 Dec; 8(18):2183-92. PubMed ID: 9449372
[TBL] [Abstract][Full Text] [Related]
9. Retroviral vectors bearing IgG-binding motifs for antibody-mediated targeting of vascular endothelial growth factor receptors.
Masood R; Gordon EM; Whitley MD; Wu BW; Cannon P; Evans L; Anderson WF; Gill P; Hall FL
Int J Mol Med; 2001 Oct; 8(4):335-43. PubMed ID: 11562769
[TBL] [Abstract][Full Text] [Related]
10. The role of the membrane-spanning domain sequence in glycoprotein-mediated membrane fusion.
Taylor GM; Sanders DA
Mol Biol Cell; 1999 Sep; 10(9):2803-15. PubMed ID: 10473628
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive mutational analysis of the Moloney murine leukemia virus envelope protein.
Rothenberg SM; Olsen MN; Laurent LC; Crowley RA; Brown PO
J Virol; 2001 Dec; 75(23):11851-62. PubMed ID: 11689666
[TBL] [Abstract][Full Text] [Related]
12. Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein.
Rein A; Mirro J; Haynes JG; Ernst SM; Nagashima K
J Virol; 1994 Mar; 68(3):1773-81. PubMed ID: 8107239
[TBL] [Abstract][Full Text] [Related]
13. Characterization of R peptide of murine leukemia virus envelope glycoproteins in syncytium formation and entry.
Kubo Y; Tominaga C; Yoshii H; Kamiyama H; Mitani C; Amanuma H; Yamamoto N
Arch Virol; 2007; 152(12):2169-82. PubMed ID: 17851730
[TBL] [Abstract][Full Text] [Related]
14. Efficient cell infection by Moloney murine leukemia virus-derived particles requires minimal amounts of envelope glycoprotein.
Bachrach E; Marin M; Pelegrin M; Karavanas G; Piechaczyk M
J Virol; 2000 Sep; 74(18):8480-6. PubMed ID: 10954548
[TBL] [Abstract][Full Text] [Related]
15. Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles.
Schnierle BS; Moritz D; Jeschke M; Groner B
Gene Ther; 1996 Apr; 3(4):334-42. PubMed ID: 8732165
[TBL] [Abstract][Full Text] [Related]
16. The fusion-controlling disulfide bond isomerase in retrovirus Env is triggered by protein destabilization.
Wallin M; Ekström M; Garoff H
J Virol; 2005 Feb; 79(3):1678-85. PubMed ID: 15650193
[TBL] [Abstract][Full Text] [Related]
17. Pseudotyping of Moloney leukemia virus-based retroviral vectors with simian immunodeficiency virus envelope leads to targeted infection of human CD4+ lymphoid cells.
Indraccolo S; Minuzzo S; Feroli F; Mammano F; Calderazzo F; Chieco-Bianchi L; Amadori A
Gene Ther; 1998 Feb; 5(2):209-17. PubMed ID: 9578840
[TBL] [Abstract][Full Text] [Related]
18. Receptor-specific targeting mediated by the coexpression of a targeted murine leukemia virus envelope protein and a binding-defective influenza hemagglutinin protein.
Lin AH; Kasahara N; Wu W; Stripecke R; Empig CL; Anderson WF; Cannon PM
Hum Gene Ther; 2001 Mar; 12(4):323-32. PubMed ID: 11242525
[TBL] [Abstract][Full Text] [Related]
19. Point mutations in Moloney murine leukemia virus envelope protein: effects on infectivity, virion association, and superinfection resistance.
Berkowitz RD; Goff SP
Virology; 1993 Oct; 196(2):748-57. PubMed ID: 8372445
[TBL] [Abstract][Full Text] [Related]
20. Jaagsiekte sheep retrovirus envelope efficiently pseudotypes human immunodeficiency virus type 1-based lentiviral vectors.
Liu SL; Halbert CL; Miller AD
J Virol; 2004 Mar; 78(5):2642-7. PubMed ID: 14963173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
